Suven Life Sciences Ltd’s net profit more than doubled at Rs 30 crore in the first quarter ended June 30 compared with Rs 7.90 crore in the year-ago period.
As per the unaudited results of the company announced here on Tuesday, the Hyderabad-based company’s increased to Rs 111.8 crore (Rs 71 crore).
The growth in profit was a result of the commercialisation of two products under contract research and manufacturing services besides increase in sales of two regular products.
A dividend of 30 paise per share (30 per cent of face value of Rs 1 each) for the accounting year 2012-13 was approved in the annual general meeting, it added.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.